SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | 0.0% | 17,085 | +23.8% | 0.00% | – |
| Q1 2022 | $16,000 | -81.6% | 13,804 | -48.1% | 0.00% | – |
| Q4 2021 | $87,000 | -84.8% | 26,603 | -79.2% | 0.00% | – |
| Q3 2021 | $571,000 | -24.2% | 127,710 | -7.5% | 0.00% | – |
| Q2 2021 | $753,000 | -13.2% | 138,135 | +19.0% | 0.00% | – |
| Q1 2021 | $868,000 | +45.4% | 116,098 | +111.0% | 0.00% | – |
| Q4 2020 | $597,000 | – | 55,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |